The anti-SLAMF7 antibody, elotuzumab, induces antibody-dependent cellular cytotoxicity against CLL cell lines
BackBibliographic information
- Publication year
- 2026
- Category
- V3 — Scientific output of publication activity from the journal
- CREPČ / EPCA ID
- 0047908
- Document type
- Journal article
- Source
- Molecules
- ISSN (Source)
- 1420-3049
- Volume
- Vol. 31, no. 3 (2026), art. no. 531, p. [1-14]
- Output type
- article
- Language
- English
- Study field
- pharmacyField group: Health sciences and fields aimed at improving the quality of life
- Research areas
- 180 — Medical, pharmaceutical and non-medical health sciences
- Links
Bibliographic record
KĽOC, Dominik - DUBIKOVÁ, Bianca - ŽILÁKOVÁ, Simona - SÝKORA, Ján - ŠULÍKOVÁ, Michaela - KURHAJEC, Slavomír - SABO, Ján - GUMAN, Tomáš - ŠARIŠSKÝ, Marek. The anti-SLAMF7 antibody, elotuzumab, induces antibody-dependent cellular cytotoxicity against CLL cell lines. In: Molecules. 2026. ISSN 1420-3049, Vol. 31, no. 3 (2026), art. no. 531, p. [1-14]. (2024: 4.6 - IF, 261 - H-index, 5 - IF 5y, 0.865 - SJR, Q1 - SJR Best Q, Q2 - JCR Best Q, 0.742 - ABDC).
Publication authors
| Author | Role | Share |
|---|---|---|
| Dominik Kľoc | Author | 33.000 % |
| Bianca Dubiková | Author | 10.000 % |
| Simona Žiláková | Author | 3.000 % |
| Ján Sýkora | Author | 5.000 % |
| Michaela Šulíková | Author | 5.000 % |
| Slavomír Kurhajec | Author | 5.000 % |
| Ján Sabo | Author | 3.000 % |
| Tomáš Guman | Author | 3.000 % |
| Marek Šarišský | Author | 33.000 % |
Metrics
IF 4.6IF5 5SJR Q 1JCR Q 2SJR 0.865H-index 261ABDC 0.742Metrics year 2024